[Answered] Acuity develops to almost 20/20 vision by the time the infant is ____

This topic contains a solution. Click here to go to the answer

Author Question: Acuity develops to almost 20/20 vision by the time the infant is _____. A) one month old B) two ... (Read 79 times)

cdr_15

Hero Member
Posts: 546

on: Jun 19, 2018

Acuity develops to almost 20/20 vision by the time the infant is _____.

A) one month old
B) two months old
C) one year old
D) two years old

Question 2

The stimuli used in the preferential looking technique of testing infant acuity are _____.

A) geons
B) gratings
C) greebles
D) graftings

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

b614102004

Sr. Member
Posts: 320

Reply #1 on: Jun 19, 2018

Answer to Question 1

C

Answer to Question 2

B

cdr_15

Member
Posts: 546

Reply 2 on: Jun 19, 2018

Excellent

cassie_ragen

Member
Posts: 347

Reply 3 on: Yesterday

YES! Correct, THANKS for helping me on my review

« previous next »

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.